Eargo 8 vs Otofonix Encore
Side-by-side HearAdvisor lab results with SoundGrades, expert pick badges, and the same visualizations we use in product reviews.

Eargo 8
The Eargo 8 is a premium-priced OTC hearing aid ($2,399) that earns a B grade with a SoundScore of 3.3/5 in our lab testing. This invisible-in-ear device represents Eargo's 2025 flagship offering, featuring a rechargeable design that sits completely within the ear canal. In our testing, the Eargo 8 showed mixed performance across key metrics. Speech clarity in quiet environments is a relative strength, scoring 0.27 points above the OTC category average. Own-voice comfort also performs well, measuring 0.69 points above average at 3.2/5—a solid result that suggests reduced occlusion effects during conversation. However, speech understanding in noisy environments scored 1.2/5, which is both low in absolute terms and 0.27 points below the category average. The most significant limitation we measured was music streaming, which scored 0.0/5—nearly 2 points below the OTC average. This makes the Eargo 8 unsuitable for users who prioritize streaming audio quality. Feedback handling is strong in absolute terms at 4.2/5, though slightly below the category average. At its premium price point, the Eargo 8 faces stiff competition. Several devices in our database deliver comparable or better sound performance at lower prices, including alternatives from Eargo's own lineup. The Eargo 8 is best suited for users who prioritize invisible cosmetics and own-voice comfort over streaming capability and value, and who primarily need help hearing speech in quieter settings.

Otofonix Encore
The Otofonix Encore is a budget-priced prescription hearing aid available for $295, earning a C grade with a SoundScore of 2.7/5 in our lab testing. This behind-the-ear device ranks #37 of 39 in the Prescription Hearing Aid category, placing it in the bottom tier of its class. In our standardized testing, the Encore demonstrates one clear strength: excellent feedback handling at 4.7/5, which means users are unlikely to experience whistling or squealing during normal use. However, the device shows significant limitations in other areas. Speech intelligibility scores are low in both quiet (1.0/5) and noisy environments (1.0/5), falling 2.40 and 1.11 points below category averages respectively. Music streaming performance scored 0.0/5, indicating this device is not suitable for those who want to stream audio content. The Encore uses disposable batteries and comes in a traditional behind-the-ear style. Notably, our tuned fit testing showed a slight decrease in overall performance compared to the initial fit, with the normalized score dropping from 2.8/5 to 2.4/5. Own-voice comfort also declined substantially when moving to a more occluding coupling. At this price point, consumers may want to consider alternatives. The RxEars Rxi offers substantially better performance at a similar budget price point with a score of 4.07/5. The Otofonix Encore may appeal to buyers seeking a very low-cost entry into prescription hearing aids who prioritize feedback stability, but those needing reliable speech clarity or streaming capabilities should explore other options.
We independently review each item we recommend and appreciate your trust and support. When you buy through our links, we may earn a commission. Learn More.
Performance metrics
Scale 1-5 (Tuned)
Speech level
Adjust input dB (Tuned)
Amplification (REIG)
Insertion gain at 65 dB (Tuned)
Audio scenes
Using MUSHRA scenes (Tuned)
Fitting configuration for tuned fit